This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: National Institute of Health and Medical Research. Active years: 2010-2016.
Company Filing History:
Years Active: 2010-2016
Title: Catherine Harb: Innovator in Interleukin-15 Research
Introduction
Catherine Harb is a prominent inventor based in Nantes, France. She has made significant contributions to the field of immunology, particularly through her research on Interleukin-15 (IL-15). With a total of 2 patents, her work focuses on the therapeutic potential of IL-15 mutants.
Latest Patents
Catherine Harb's latest patents include innovations related to IL-15 mutants having antagonist activity. The first patent describes the identification of an epitope in human Interleukin-15 that is responsible for binding to the interleukin-15 receptor α-chain. Two regions of IL-15 are involved in forming this epitope: the first region (LLELQVISL, peptide 1) is located in the B helix, while the second (ENLII, peptide 2 or ENLIIL, peptide 2a) is found in helix C. These muteins, displaying agonist or antagonist properties, may serve as valuable therapeutic agents. The second patent similarly focuses on IL-15 mutants having agonist/antagonist activity, emphasizing their potential in medical applications.
Career Highlights
Catherine Harb is affiliated with the National Institute of Health and Medical Research, where she conducts her research. Her work has garnered attention for its innovative approach to understanding IL-15 and its implications in therapeutic settings.
Collaborations
Catherine collaborates with notable colleagues, including Jérôme Bernard and Ariane Plet. Their combined expertise contributes to advancing research in the field of immunology.
Conclusion
Catherine Harb's contributions to the study of Interleukin-15 highlight her role as an influential inventor in the field of immunology. Her patents reflect her commitment to developing therapeutic solutions that may benefit patients in the future.